<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9277450" created="02/06/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9277450</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="surfactant_protein_A" sem="Protein_molecule">Surfactant protein A</term> activates <term id="T2" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> in the <term id="T3" lex="THP-1_monocytic_cell_line" sem="Cell_cultured">THP-1 monocytic cell line</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="T2"/>
<cause idref="T1"/>
<clue>Surfactant protein A <clueType>activates</clueType> NF-kappa B <clueLoc>in the THP-1 monocytic cell line</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The expression of <term id="T30" sem="DNA_domain_or_region">many genes</term> for which products are involved in <term id="T4" lex="inflammation" sem="Other">inflammation</term> is controlled by the <term id="T5" lex="transcriptional_regulator_nuclear_factor_(NF)-kappa_B" sem="Protein_complex">transcriptional regulator nuclear factor <term id="A2" sem="Protein_complex">(NF)-kappa B</term></term>.</sentence>
<event KT="Other" id="E2">
<type class="Gene_expression"/>
<theme idref="T30"/>
<clue>The <clueType>expression</clueType> <linkTheme>of</linkTheme> many genes for which products are involved in inflammation is controlled by the transcriptional regulator nuclear factor (NF)-kappa B.</clue>
<comment>TPS: A1</comment></event>
<event KT="Fact" id="E3">
<type class="Regulation"/>
<theme idref="E2"/>
<cause idref="A2"/>
<clue>The expression of many genes for which products are involved in inflammation is <clueType>controlled</clueType> <linkCause>by</linkCause> the transcriptional regulator nuclear factor (NF)-kappa B.</clue>
</event>
<sentence id="S3">Because <term id="T6" lex="surfactant_protein_(SP)_A" sem="Protein_molecule">surfactant protein (SP) A</term> is involved in local <term id="A3" sem="Other">host defense</term> in the <term id="T7" lex="lung" sem="Body_region">lung</term> and alters <term id="T8" lex="immune_cell_function" sem="Other">immune cell function</term> by modulating the expression of <term id="T9" lex="proinflammatory_cytokine" sem="Protein_family_or_group">proinflammatory cytokines</term> as well as <term id="T10" lex="surface_protein" sem="Protein_family_or_group">surface proteins</term> involved in <term id="T11" lex="inflammation" sem="Other">inflammation</term>, we hypothesized that <term id="T12" lex="SP-A" sem="Protein_molecule">SP-A</term> exerts its action, at least in part, via activation of <term id="T13" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term>.</sentence>
<event KT="Fact" id="E4">
<type class="Regulation"/>
<theme idref="A3"/>
<cause idref="T6"/>
<clue>Because surfactant protein (SP) A is <clueType>involved</clueType> <linkTheme>in</linkTheme> local host defense <clueLoc>in the lung</clueLoc> and alters immune cell function by modulating the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Regulation"/>
<theme idref="T8"/>
<cause idref="E6"/>
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and <clueType>alters</clueType> immune cell function <linkCause>by</linkCause> modulating the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event KT="Fact" id="E11">
<type class="Regulation"/>
<theme idref="T8"/>
<cause idref="E7"/>
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and <clueType>alters</clueType> immune cell function <linkCause>by</linkCause> modulating the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event KT="Other" id="E6">
<type class="Regulation"/>
<theme idref="E8"/>
<cause idref="T6"/>
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and alters immune cell function by <clueType>modulating</clueType> the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event KT="Other" id="E7">
<type class="Regulation"/>
<theme idref="E9"/>
<cause idref="T6"/>
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and alters immune cell function by <clueType>modulating</clueType> the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event KT="Other" id="E8">
<type class="Gene_expression"/>
<theme idref="T9"/>
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and alters immune cell function by modulating the <clueType>expression</clueType> <linkTheme>of</linkTheme> proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event KT="Other" id="E9">
<type class="Gene_expression"/>
<theme idref="T10"/>
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and alters immune cell function by modulating the <clueType>expression</clueType> <linkTheme>of</linkTheme> proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event KT="Other" id="E10">
<type class="Regulation"/>
<theme idref="T11"/>
<cause idref="T10"/>
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and alters immune cell function by modulating the expression of proinflammatory cytokines as well as surface proteins <clueType>involved</clueType> <linkTheme>in</linkTheme> inflammation, we hypothesized that SP-A exerts its action, at least in part, via activation of NF-kappa B.</clue>
</event>
<event CL="L2" KT="Analysis" id="E12" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E5"/>
<cause idref="E15"/>
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and alters immune cell function by modulating the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we <clueKT><clueCL>hypothesized</clueCL></clueKT> that SP-A <clueType>exerts</clueType> <corefTheme>its action</corefTheme>, at least in part, <linkCause>via</linkCause> activation of NF-kappa B.</clue>
</event>
<event CL="L2" KT="Analysis" id="E13" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="E11"/>
<cause idref="E15"/>
<clue>Because surfactant protein (SP) A is involved in local host defense <clueLoc>in the lung</clueLoc> and alters immune cell function by modulating the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we <clueKT><clueCL>hypothesized</clueCL></clueKT> that SP-A <clueType>exerts</clueType> <corefTheme>its action</corefTheme>, at least in part, <linkCause>via</linkCause> activation of NF-kappa B.</clue>
</event>
<event KT="Other" id="E15">
<type class="Positive_regulation"/>
<theme idref="T13"/>
<cause idref="T12"/>
<clue>Because surfactant protein (SP) A is involved in local host defense in the lung and alters immune cell function by modulating the expression of proinflammatory cytokines as well as surface proteins involved in inflammation, we hypothesized that SP-A exerts its action, at least in part, via <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B.</clue>
</event>
<sentence id="S4">We used gel shift assays to determine whether <term id="T14" lex="SP-A" sem="Protein_molecule">SP-A</term> activated <term id="T15" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> in the <term id="T16" lex="THP-1_cell_line" sem="Cell_cultured">THP-1 cell line</term>, a <term id="T17" lex="human_monocytic_cell_line" sem="Cell_cultured">human monocytic cell line</term>.</sentence>
<event KT="Investigation" id="E16" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="T15"/>
<cause idref="T14"/>
<clue>We used <clueExperiment>gel shift assays</clueExperiment> <clueKT>to determine</clueKT> whether SP-A <clueType>activated</clueType> NF-kappa B <clueLoc>in the THP-1 cell line, a human monocytic cell line</clueLoc>.</clue>
</event>
<sentence id="S5">Activation of <term id="T18" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term> in <term id="T19" lex="THP-1_cell" sem="Cell_cultured">THP-1 cells</term> by <term id="T20" lex="SP-A" sem="Protein_molecule">SP-A</term> doses as low as 1 microgram/ml occurred within 30 min of <term id="T21" lex="SP-A_treatment" sem="Other"><term id="T22" lex="SP-A" sem="Protein_molecule">SP-A</term> treatment</term>, peaked at 60 min, and then declined.</sentence>
<event id="E17">
<type class="Positive_regulation"/>
<theme idref="T18"/>
<cause idref="T20"/>
<clue><clueType>Activation</clueType> <linkTheme>of</linkTheme> NF-kappa B <clueLoc>in THP-1 cells</clueLoc> <linkCause>by</linkCause> SP-A doses as low as 1 microgram/ml occurred <clueTime>within 30 min of SP-A treatment, peaked at 60 min</clueTime>, and then declined.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E18">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<clue>Activation of NF-kappa B in THP-1 cells by SP-A doses as low as 1 microgram/ml occurred within 30 min of SP-A treatment, peaked at 60 min, and <clueTime>then</clueTime> <clueType><cluePolarity>declined</cluePolarity></clueType>.</clue>
</event>
<sentence id="S6">This activation is inhibited by known <term id="A4" sem="Protein_family_or_group">inhibitors of <term id="T23" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term></term> or by simultaneous treatment of the cells with <term id="T24" lex="surfactant_lipid" sem="Lipid">surfactant lipids</term>.</sentence>
<event id="E19">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<cause idref="A4"/>
<clue><corefTheme>This activation</corefTheme> is <clueType>inhibited</clueType> <linkCause>by</linkCause> known inhibitors of NF-kappa B or by simultaneous treatment of the cells with surfactant lipids.</clue>
<comment>TPS: A4</comment></event>
<event id="E20">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<cause idref="E21"/>
<clue><corefTheme>This activation</corefTheme> is <clueType>inhibited</clueType> by known inhibitors of NF-kappa B or <linkCause>by</linkCause> <clueTime>simultaneous</clueTime> treatment of the cells with surfactant lipids.</clue>
</event>
<event KT="Method" id="E21">
<type class="Artificial_process"/>
<theme idref="T19"/>
<theme idref="T24"/>
<clue>This activation is inhibited by known inhibitors of NF-kappa B or by simultaneous <clueType>treatment</clueType> <linkTheme>of</linkTheme> <corefTheme>the cells</corefTheme> <linkTheme>with</linkTheme> surfactant lipids.</clue>
</event>
<sentence id="S7">Moreover, the <term id="T25" lex="NF-kappa_B_inhibitor" sem="Protein_family_or_group"><term id="T26" lex="NF-kappa_B" sem="Protein_molecule"><term id="T27" lex="NF-kappa_B" sem="Protein_complex">NF-kappa B</term></term> inhibitors</term> blocked <term id="T29" lex="SP-A" sem="Protein_molecule">SP-A</term>-dependent <term id="T28" sem="Other">increases</term> in <term id="T31" lex="tumor_necrosis_factor-alpha_mRNA" sem="RNA_molecule">tumor necrosis factor-alpha mRNA</term> levels.</sentence>
<event KT="Other" id="E22">
<type class="Positive_regulation"/>
<theme idref="T31"/>
<cause idref="T29"/>
<clue>Moreover, the NF-kappa B inhibitors blocked SP-A<linkCause>-dependent</linkCause> <clueType>increases</clueType> <linkTheme>in</linkTheme> tumor necrosis factor-alpha mRNA levels.</clue>
</event>
<event id="E23">
<type class="Negative_regulation"/>
<theme idref="E22"/>
<cause idref="T25"/>
<clue>Moreover, the NF-kappa B inhibitors <clueType>blocked</clueType> SP-A-dependent increases in tumor necrosis factor-alpha mRNA levels.</clue>
</event>
<sentence id="S8">These observations suggest a mechanism by which <term id="T32" lex="SP-A" sem="Protein_molecule">SP-A</term> plays a role in the <term id="T39" sem="Other">pathogenesis</term> of some <term id="T33" lex="lung_condition" sem="Other"><term id="T34" lex="lung" sem="Body_region">lung</term> conditions</term> and point to <term id="T35" lex="potential_therapeutic_measure" sem="Other">potential therapeutic measures</term> that could be used to prevent <term id="T36" lex="SP-A" sem="Protein_molecule">SP-A</term> induced <term id="T37" lex="inflammation" sem="Other">inflammation</term> in the <term id="T38" lex="lung" sem="Body_region">lung</term>.</sentence>
<event CL="L2" KT="Analysis" id="E24" uncertainty="probable">
<type class="Regulation"/>
<theme idref="T39"/>
<cause idref="T32"/>
<clue>These observations <clueKT><clueCL>suggest</clueCL></clueKT> a mechanism by which SP-A <clueType>plays a role</clueType> <linkTheme>in</linkTheme> the pathogenesis of some lung conditions and point to potential therapeutic measures that could be used to prevent SP-A induced inflammation in the lung.</clue>
</event>
<event CL="L1" KT="Analysis" id="E25" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E26"/>
<clue>These observations suggest a mechanism by which SP-A plays a role in the pathogenesis of some lung conditions and point to <clueKT>potential</clueKT> therapeutic measures that <clueCL>could</clueCL> be used to <clueType>prevent</clueType> SP-A induced inflammation in the lung.</clue>
</event>
<event KT="Other" id="E26" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="T37"/>
<cause idref="T36"/>
<clue>These observations suggest a mechanism by which SP-A plays a role in the pathogenesis of some lung conditions and point to potential therapeutic measures that could be used to prevent SP-A <clueType>induced</clueType> inflammation <clueLoc>in the lung</clueLoc>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
